Efecto del Tratamiento Periodontal no Quirúrgico en los Niveles de MMP-2 y TIMP-2 en Periodontitis Crónica | Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral

Información del artículo

Resumen

La MMP-2 es una gelatinasa envuelta en la degradación de la matriz extracelular ya sea directamente por sus efectos degradativos o por la capacidad de procesar sustratos bioactivos. El objetivo de este estudio fue determinar el efecto del tratamiento periodontal no quirúrgico en los niveles de MMP-2 y TIMP-2 en el fluído gingival crevicular (FGC) de sitios con periodontitis crónica.

Materiales y Métodos

Se estudiaron sitios de individuos con periodontitis crónica los cuales fueron seguidos hasta completar el tratamiento periodontal no quirúrgico. Se obtuvieron biopsias (pre-tratamiento) y FGC (pre y post tratamiento) de sitios con periodontitis crónica y de sitios sanos. Se observó la expresión de MMP-2 y TIMP-2 en tejidos gingivales enfermos y sanos mediante inmunohistoquímica y se determinaron sus niveles mediante la técnica ELISA.

Resultados

Observamos presencia de MMP-2 y TIMP-2 en biopsias de sitios con periodontitis (pre-tratamiento) y sitios sanos. Los niveles de MMP-2 fueron mayores en el FGC de individuos con periodontitis en comparación a individuos sanos. Los niveles de MMP-2 disminuyeron en los sitios afectados luego de realizado el tratamiento periodontal no quirúrgico. No encontramos diferencias significativas en los niveles de TIMP-2 al comparar sitios antes o después del tratamiento.

Conclusión

La MMP-2 podría tener un rol dentro de los fenómenos de destrucción tisular que caracteriza a la periodontitis cónica. El tratamiento periodontal no quirúrgico disminuye los niveles de MMP-2 en sitios con periodontitis crónica.

Palabras clave:

MMP-2

TIMP-2

fluido gingival crevicular

tratamiento periodontal

Abstract

Matrix metalloproteinase (MMP)-2 is a gelatinase involved in extracellular matrix degradation either by its direct degradative effects or by processing bioactive substrates. The aim of this study was to determine the effect of conventional tratment in the levels of MMP-2 and tissue inhibitor of metalloproteinase (TIMP)-2 in gingival crevicular fluid (GCF) of chronic periodontitis patients.

Materials and Methods

In this study chronic periodontitis patients with moderate to severe disease were followed until they complete the non-surgical periodontal theraphy. Gingival biopses were obteined from periodontitis (pre-treatment) and healty sites. GCF samples were obteined from periodontitis (pre and post treatment) and healthy sites. MMP-2 and TIMP-2 detection were carried out by immunihistochemistry and levels determination by enzyme-linked immunosorbent assay (ELISA).

Results

We observed the expression of MMP-2 y TIMP-2 in gingival biopses from periodontitis (pre-treatment) and healthy sites. The levels of MMP-2 were higher in GCF of disease sites in relation to healthy sites and lower post-treatment sites in comparation with pre-treatment sites. There were no significant diferences in the levels of TIMP-2 before or after nonsurgical periodontal treatment.

Conclusion

MMP-2 could play a role in tissue destruction a characteristic of chronic periodontitis. Nonsurgical periodontal treatment decrease the levels of MMP-2 in sites with chronic periodontitis.

Key words:

MMP-2

TIMP-2

gingival crevicular fluid

periodontal treatment

El Texto completo está disponible en PDF

Referencias bibliográficas

[1.]

Belibasakis, et al.

Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin.

Cytokine., (2005), pp. 56-63

[2.]

G. Seymour, E. Gemmell.

Cytokines in periodontal disease: where to from here?.

Acta Odontol Scand, 59 (2001), pp. 167-173

Medline

[3.]

R. Page.

The role of inflammatory meditors in the pathogenesis of periodontal disease.

J Periodontal Research., 26 (1991), pp. 230-242

[4.]

A.L. Ejeil, S.I. Tchen, S. Ghomrasseni, et al.

Expression of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases (TIMPs) in healthy and diseased human gingival.

J Periodontol., 74 (2003), pp. 188-195

http://dx.doi.org/10.1902/jop.2003.74.2.188 | Medline

[5.]

T. Tervahartiala, E. Prilia, A. Ceponis, et al.

The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8 -13 and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontits.

J Dent Res, 79 (2000), pp. 1969-1977

Medline

[6.]

L. Goncalves, G. Oliveira, Hurtado, et al.

Expression of metalloproteinases and their tissue inhibitors in inflamed gingival biopsies.

J Periodont Res, 43 (2008), pp. 570-577

http://dx.doi.org/10.1111/j.1600-0765.2008.01101.x | Medline

[7.]

M. Hernández, B. Martínez.

Tejerina et al MMP-13 and TIMP-1 determinations in progressive chronic periodontitis.

J Clin Periodontol., 34 (2007), pp. 729-735

http://dx.doi.org/10.1111/j.1600-051X.2007.01107.x | Medline

[8.]

M. Danilewicz, B. Sikorska, M. Wagrowska-Danilewicz.

Prognostic signiﬁcance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer.

Med Sci Monit, 9 (2003), pp. MT42-MT47

Medline

[9.]

I. Kazes, I. Elalamy, J.D. Sraer, et al.

Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation.

Blood, 96 (2000), pp. 3064-3069

Medline

[10.]

G. Tüter, B. Kurtiş, M. Serdar.

Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.

J Periodontol, 73 (2002), pp. 487-493

http://dx.doi.org/10.1902/jop.2002.73.5.487 | Medline

[11.]

G. Tüter, B. Kurtiş, M. Serdar, A. Yücel, E. Ayhan, B. Karaduman, G. Ozcan.

Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase- 3 and tissue inhibitor of metalloproteinase-1.

J Clin Periodontol, 32 (2005), pp. 1011-1015

http://dx.doi.org/10.1111/j.1600-051X.2005.00816.x | Medline

[12.]

H. Nagase.

Activation mechanisms of matrix metalloproteinases.

Biol Chem, 378 (1997), pp. 151-160

Medline

[13.]

S. Leppa, T. Saarto, L. Vehmanen, et al.

High serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma.

Clin Cancer Res, 10 (2004), pp. 1057-1063

Medline

[14.]

Emingil, et al.

Gingival crevicular fluid MMP-25 and -26 levels of patients with periodontal disease.

J Clin Periodontol., 77 (2006), pp. 664-671

[15.]

P. Pozo, et al.

Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients.

J Periodontal Res., 40 (2005), pp. 199-207

http://dx.doi.org/10.1111/j.1600-0765.2005.00786.x | Medline

[16.]

G.P. Garlet, J.W. Martins, Fonseca BAl, et al.

Matrix metalloproteinases, their physiologucal inhibitors and osteoclasts factors are differentially regulated by the citokine profile in human periodontal disease.

J Clin Periodontol., 31 (2004), pp. 671-679

http://dx.doi.org/10.1111/j.1600-051X.2004.00545.x | Medline

[17.]

M.C. Meikle, R.M. Hembry, J. Holley, et al.

Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients.

J Periodontal Res., 29 (1994), pp. 118-126

Medline

[18.]

A. Bordineau, G. Godeau, N. Brousse, et al.

Langerhans cells express matrix metalloproteinases 9 and 2 and tissue inhibitors of metalloproteinases 1 and 2 in healthy human gingival tissea and in periodontitis.

Oral Microbiology Immunology, 21 (2006), pp. 197-200

http://dx.doi.org/10.1111/j.1399-302X.2006.00261.x | Medline

[19.]

S. Lin, C. Chiang, C. Hong, et al.

Immunolocalization of interstitial collagenase (MMP-1) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in radicular cysts.

J Oral Pathol Med., 26 (1997), pp. 458-463

Medline

[20.]

J. Zhou, L.J. Windsor.

Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.

J Periodontal Res., 41 (2006), pp. 47-54

http://dx.doi.org/10.1111/j.1600-0765.2005.00835.x | Medline

[21.]

H. Qin, Y. Sun, E.N. Benveniste.

The transcription factors Sp1 Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells.

J Biol Chem, 274 (1999), pp. 29130-29137

Medline

[22.]

T. Katono, T. Kawato, N. Tanabe.

Effects of nicotine and lipopolysaccharide on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in human osteoblasts.

Arch Oral Biol., 54 (2009), pp. 146-155

http://dx.doi.org/10.1016/j.archoralbio.2008.09.017 | Medline

[23.]

B.S. Kang, Y.G. Park, J.Y. Cho, et al.

Interleukin-1 and tumor necrosis factor-alpha induce collagenolysis and bone resorption by regulation of matrix metalloproteinase-2 in mouse calvarial bone cells.

Immunopharmacol Immunotoxicol., 25 (2003), pp. 347-364

Medline

[24.]

D.T. Graves, D. Cochran.

The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction.

J Periodontol., 74 (2003), pp. 391-401

http://dx.doi.org/10.1902/jop.2003.74.3.391 | Medline

[25.]

R. Rutherford.

Cirugía vascular.

6a, Elsevier, (2006), pp. 479

[26.]

C. Damiens, Y. Fortun, C. Charrier, et al.

Modulation by soluble factors of gelatinase activities released by osteoblastic cells.

Cytokine., 12 (2000), pp. 1727-1731

http://dx.doi.org/10.1006/cyto.2000.0765 | Medline

[27.]

L. Golub, H. Lee, R. Greenwald, et al.

A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in GCF during periodontits.

Inflamm Res, 46 (1997), pp. 310-319

http://dx.doi.org/10.1007/s000110050193 | Medline

[28.]

E. Adonogianaki, J. Mooney, D.F. Kinane.

Detection of stable and active periodontitis sites by clinical assessment and gingival crevicular acute-phase protein levels J Periodontal Res., 31 (1996), pp. 135-143

[29.]

I.E. Collier, S.M. Wilhelm, A.Z. Eisen, B.L. Marmer, G.A. Grant, J.L. Seltzer, A. Kronberger, C.S. He, E.A. Bauer, G.I. Goldberg.

H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

J Biol Chem, 263 (1988), pp. 6579-6587

Medline

[30.]

R. Achong, I. Nishimura, H. Ramachandran.

Membrane type (MT) 1-matrix metalloproteinase (MMP) and MMP-2 expression in ligature-induced periodontitis in the rat.

J Periodontol., 74 (2003), pp. 494-500

http://dx.doi.org/10.1902/jop.2003.74.4.494 | Medline

[31.]

J.M. Korostoff, J.F. Wang, D.P. Sarment, et al.

Analysis of in situ Proteinase activity in chronic adult periodontitis patients: Expression of activated MMP-2 and 40-kDa serin protease.

J Periodontol, 71 (2000), pp. 353-360

http://dx.doi.org/10.1902/jop.2000.71.3.353 | Medline

Indexada en:

Síguenos:

Indexada en:

Síguenos:

Suscríbase a la newsletter